Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Non-Current Assets: 2017-2020

  • Sunshine Biopharma's Other Non-Current Assets changed negligibly% to $7,590 in Q4 2020 from the same period last year, while for Dec 2020 it was $7,590, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $7,590 for FY2020, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2020, Sunshine Biopharma's Other Non-Current Assets is $7,590, which was down 0.00% from $7,590 recorded in Q4 2019.
  • In the past 5 years, Sunshine Biopharma's Other Non-Current Assets ranged from a high of $989,572 in Q4 2018 and a low of $7,590 during Q4 2019.
  • Over the past 3 years, Sunshine Biopharma's median Other Non-Current Assets value was $7,590 (recorded in 2020), while the average stood at $334,917.
  • In the last 5 years, Sunshine Biopharma's Other Non-Current Assets soared by 1,132.50% in 2018 and then tumbled by 99.23% in 2019.
  • Sunshine Biopharma's Other Non-Current Assets (Quarterly) stood at $80,290 in 2017, then skyrocketed by 1,132.50% to $989,572 in 2018, then plummeted by 99.23% to $7,590 in 2019, then remained steady at $7,590 in 2020.
  • Its Other Non-Current Assets stands at $7,590 for Q4 2020, versus $7,590 for Q4 2019 and $989,572 for Q4 2018.